Royal Bank of Canada’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36K Buy
2,590
+780
+43% +$12K ﹤0.01% 5645
2025
Q4
$23K Buy
1,810
+52
+3% +$708 ﹤0.01% 5962
2025
Q3
$25K Sell
1,758
-104
-6% -$1.46K ﹤0.01% 6120
2025
Q2
$23K Buy
1,862
+762
+69% +$8.35K ﹤0.01% 6210
2025
Q1
$12K Buy
1,100
+100
+10% +$1.12K ﹤0.01% 6093
2024
Q4
$7K Hold
1,000
﹤0.01% 6446
2024
Q3
$7K Sell
1,000
-97
-9% -$995 ﹤0.01% 6424
2024
Q2
$13K Buy
1,097
+97
+10% +$1.16K ﹤0.01% 6240
2024
Q1
$11K Hold
1,000
﹤0.01% 6163
2023
Q4
$6K Hold
1,000
﹤0.01% 6616
2023
Q3
$10K Hold
1,000
﹤0.01% 6413
2023
Q2
$12K Hold
1,000
﹤0.01% 6411
2023
Q1
$8K Hold
1,000
﹤0.01% 6408
2022
Q4
$10K Hold
1,000
﹤0.01% 6544
2022
Q3
$12K Sell
1,000
-4,466
-82% -$56.3K ﹤0.01% 6348
2022
Q2
$55K Buy
+5,466
New +$71K ﹤0.01% 5670

Other funds holding GHRS

Royal Bank of Canada's GHRS Position: Q1 2026 in Review

Royal Bank of Canada increased its GH Research (GHRS) stake by 43% in Q1 2026, buying an estimated $12K and bringing the position to 2,590 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #5645.

Royal Bank of Canada first reported a position in GHRS in Q2 2022 and has held it in 16 quarters since. The position peaked at $55K in Q2 2022. 54 funds tracked by Wall St. Rank hold GHRS as of Q1 2026.

  • Royal Bank of Canada held 2,590 shares of GH Research worth $36K as of Q1 2026.
  • Royal Bank of Canada bought 780 GH Research shares in Q1 2026, an estimated $12K.
  • GH Research made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5645 holding.
  • Royal Bank of Canada first reported a position in GH Research in Q2 2022 and has held it in 16 quarters since.
  • Royal Bank of Canada's GH Research position peaked at $55K in Q2 2022.
  • 54 funds tracked by Wall St. Rank held GH Research as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.